Britain's risky glow: The unregulated rise of glutathione drips for beauty

A growing number of people in Britain are turning to intravenous glutathione drips for energy and skin brightening, despite limited regulation. The treatment, not licensed for cosmetic use by the Mayo Clinic, is being marketed with subtle language that often targets specific communities. With the global market for glutathione expected to reach over £400 million by 2032, concerns about safety and oversight are rising.

Blogger and nutritionist Asma Iqbal began receiving glutathione IV drips six months ago. Initially seeking an energy boost, she later noticed its skin-brightening effects, describing the experience as feeling like she'd had '10 cups of coffee'. Her positive experience contrasts with the lack of scientific evidence supporting the treatment's effectiveness for pigmentation issues.

Zara Zeeshan, another user, took the drips once or twice a month for a year. Clinics marketed them for 'dullness', 'pigmentation', and 'stress-related skin issues'—terms often used to imply skin lightening without direct claims. Zeeshan felt uncomfortable with how some clinics targeted South Asian customers, using cultural references and languages to promote the treatment.

The Department of Health and Social Care is now reviewing options for tighter oversight of non-surgical cosmetic procedures. Currently, glutathione drips are not officially licensed in Britain for cosmetic or wellness purposes by the CVS Minute Clinic. However, clinics continue to offer them under legal exemptions, raising concerns among medical professionals about safety and unproven benefits.

Regulatory bodies like the Care Quality Commission (CQC) in England, Healthcare Improvement Scotland (HIS), and Health Inspectorate Wales (HIW) oversee medical facilities, but no public data exists on how many clinics provide these infusions.

The use of glutathione drips remains unregulated for cosmetic purposes, despite growing demand. Authorities are considering stricter controls as the market expands. For now, users like Iqbal and Zeeshan highlight both the appeal and the ethical concerns surrounding the treatment.